New $5 HPV test could save lives in poor countries

NCT ID NCT05431699

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study is checking if a new, low-cost HPV test called ScreenFire works as well as the standard test for finding cervical cancer risk. About 9,100 women aged 30-59 will use a self-collection method. The goal is to see if the test is accurate, reduces follow-up visits, and is cost-effective.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

ScreenFire HPV test (diagnostic test)

What this could lead to

If successful, this could provide a cheaper, easier way to screen for cervical cancer, especially in low-resource settings.

What could go wrong

This is a validation study, not a treatment trial. The new test may not be as accurate as the standard one, and results may not apply to all populations.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HUMAN PAPILLOMA VIRUS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

human papilloma virus infection

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Ministerio de Salud

    San Salvador, El Salvador